STAMATAKOS, SERENA

STAMATAKOS, SERENA  

DIPARTIMENTO DI FARMACIA E BIOTECNOLOGIE  

Dottorandi  

Mostra records
Risultati 1 - 8 di 8 (tempo di esecuzione: 0.015 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences Costa G.; Caputi F.F.; Serra M.; Simola N.; Rullo L.; Stamatakos S.; Sanna F.; Germain M.; Martin...oli M.-G.; Candeletti S.; Morelli M.; Romualdi P. 2021-01-01 FRONTIERS IN PHARMACOLOGY - 1.01 Articolo in rivista fphar-12-713486.pdf
Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy Lucia Carboni; Laura Rullo; Francesca Felicia Caputi; Serena Stamatakos; Sanzio Candeletti; Patri...zia Romualdi 2022-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-23-14041 (1).pdf
Early-life nicotine or cotinine exposure produces long-lasting sleep alterations and downregulation of hippocampal corticosteroid receptors in adult mice Bastianini S.; Lo Martire V.; Alvente S.; Berteotti C.; Matteoli G.; Rullo L.; Stamatakos S.; Sil...vani A.; Candeletti S.; Romualdi P.; Cohen G.; Zoccoli G. 2021-01-01 SCIENTIFIC REPORTS - 1.01 Articolo in rivista BastianiniSREP2021.pdf41598_2021_3468_MOESM7_ESM.zip
Interplay between the endogenous opioid system and proteasome complex: Beyond signaling Caputi F.F.; Rullo L.; Stamatakos S.; Candeletti S.; Romualdi P. 2019-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-20-01441.pdf
Modulation of the negative affective dimension of pain: Focus on selected neuropeptidergic system contributions Caputi F.F.; Rullo L.; Stamatakos S.; Candeletti S.; Romualdi P. 2019-01-01 INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES - 1.01 Articolo in rivista ijms-20-04010.pdf
Nociceptive behavior and central neuropeptidergic dysregulations in male and female mice of a Fabry disease animal model Rullo L.; Posa L.; Caputi F.F.; Stamatakos S.; Formaggio F.; Caprini M.; Liguori R.; Candeletti S....; Romualdi P. 2021-01-01 BRAIN RESEARCH BULLETIN - 1.01 Articolo in rivista -
Targeting the JAK/STAT Pathway: A Combined Ligand- And Target-Based Approach Galvez-Llompart M.; Ocello R.; Rullo L.; Stamatakos S.; Alessandrini I.; Zanni R.; Tunon I.; Cava...lli A.; Candeletti S.; Masetti M.; Romualdi P.; Recanatini M. 2021-01-01 JOURNAL OF CHEMICAL INFORMATION AND MODELING - 1.01 Articolo in rivista acs.jcim.2021_1.pdf
The active second-generation proteasome inhibitor oprozomib reverts the oxaliplatin-induced neuropathy symptoms Caputi F.F.; Di Cesare Mannelli L.; Rullo L.; Micheli L.; Stamatakos S.; Posa L.; Ghelardini C.; ...Romualdi P.; Candeletti S. 2020-01-01 BIOCHEMICAL PHARMACOLOGY - 1.01 Articolo in rivista TrackChangesCaputietal.2020Bioch Pharmrev28920(1).pdf